Gilead 2018

Discussion in 'Gilead Sciences' started by anonymous, Feb 20, 2018 at 12:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    hoping this is a breakout year for Gilead.
     

  2. anonymous

    anonymous Guest

    Immoral Gilead needs to reduce their Rx prices!!
     
  3. anonymous

    anonymous Guest

    no thanks.
     
  4. anonymous

    anonymous Guest

    Drug prices are just fine.
     
  5. anonymous

    anonymous Guest

    stock price will hit 100bthis year.
     
  6. anonymous

    anonymous Guest

    2018 just got a li
     
  7. anonymous

    anonymous Guest

    Isn’t Korab Zuka at Gilead now and wasn’t he a VP at the Patient Access Network Foundation (PAN), which is now under investigation with the OIG for running a co-payment assistance/scheme with Pfizer? And, Pfizer just settled on this for $25 M. I find it interesting that the same person responsible for this is not part of Gikead’s Public Affairs team. Sad, really.
     
  8. anonymous

    anonymous Guest

    I hope so. Then I can dump this dog of a stock with at least a small profit. The glory days of Gilead are far in the past. The only thing they have proven in the past couple of years is they can't seem to make good decisions anymore.
     
  9. anonymous

    anonymous Guest

     
  10. anonymous

    anonymous Guest

    I like Korab!